Loading…

Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study

CRT Patient Characteristics and Outcomes. Introduction: The characteristics and outcomes of patients who undergo cardiac resynchronization therapy (CRT) device implantation in current clinical practice may differ from those of reference trial populations. Study objectives were to assess 2‐year outco...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cardiovascular electrophysiology 2013-02, Vol.24 (2), p.173-181
Main Authors: BOTTO, GIOVANNI LUCA, DICANDIA, COSIMO DAMIANO, MANTICA, MASSIMO, ROSA, CONCETTO LA, D'ONOFRIO, ANTONIO, BONGIORNI, MARIA GRAZIA, MOLON, GIULIO, VERLATO, ROBERTO, VILLANI, GIOVANNI QUINTO, SCACCIA, ALBERTO, RACITI, GIOVANNI, OCCHETTA, ERALDO
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243
cites cdi_FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243
container_end_page 181
container_issue 2
container_start_page 173
container_title Journal of cardiovascular electrophysiology
container_volume 24
creator BOTTO, GIOVANNI LUCA
DICANDIA, COSIMO DAMIANO
MANTICA, MASSIMO
ROSA, CONCETTO LA
D'ONOFRIO, ANTONIO
BONGIORNI, MARIA GRAZIA
MOLON, GIULIO
VERLATO, ROBERTO
VILLANI, GIOVANNI QUINTO
SCACCIA, ALBERTO
RACITI, GIOVANNI
OCCHETTA, ERALDO
description CRT Patient Characteristics and Outcomes. Introduction: The characteristics and outcomes of patients who undergo cardiac resynchronization therapy (CRT) device implantation in current clinical practice may differ from those of reference trial populations. Study objectives were to assess 2‐year outcomes in a population implanted with a CRT plus defibrillator device in accordance with the standard of care and to evaluate any independent association between clinical variables and outcome. Methods and Results: A total of 406 patients enrolled at 35 centers in Italy were followed up prospectively for 2 years. All patient management decisions were left to the treating physician's discretion, in accordance with clinical practice. ACTION‐HF patients had a better baseline clinical status than patients enrolled in the COMPANION study: shorter HF history (1 vs 3.5 years, P 
doi_str_mv 10.1111/jce.12023
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1316376951</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2879959971</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243</originalsourceid><addsrcrecordid>eNp1kd9u0zAUhyMEYmNwwQsgS9yA1Gy2T2Kn3HVhW4vGhkoHl5ZjO6u7_Cm2Iwivw4virdsukLBk-ej4O5-O9EuS1wQfkniONsocEoopPEn2SZ7htCCMP401zvIUCg57yQvvNxgTYDh_nuxRIIB5QfaTP2VjO6tkg8q1dFIF46wPVvkJ-ty7IBsbxgkqpdNWKjTv_dbeNn_LYPtugmSn0TfTBWfV0EiHZs6tx7BurfTIduhLxOKvR1edNu66t901Kper9CNatNtGduFO8wEtjR-aiPU1CmuDZuVqcXmRzk_R1zDo8WXyrJaNN6_u34Pk6vRkVc7T88uzRTk7TxVMCaSGUgBQmvO8wCpTBGhdAyWSqnrKKqM1Y7qqClbXlckyHm9VU80N4zLjNIOD5N3Ou3X9j8H4IFrrlWnioqYfvCBAGHA2zUlE3_6DbvrBdXE7QWgBlGbTnEfq_Y5SrvfemVpsnW2lGwXB4jY5EZMTd8lF9s29cahaox_Jh6gicLQDftrGjP83iU_lyYMy3U3ERM2vxwnpbgTjwHPx_eJMHPNimR-zXMzhL5OhsgI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1283224957</pqid></control><display><type>article</type><title>Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study</title><source>Wiley</source><creator>BOTTO, GIOVANNI LUCA ; DICANDIA, COSIMO DAMIANO ; MANTICA, MASSIMO ; ROSA, CONCETTO LA ; D'ONOFRIO, ANTONIO ; BONGIORNI, MARIA GRAZIA ; MOLON, GIULIO ; VERLATO, ROBERTO ; VILLANI, GIOVANNI QUINTO ; SCACCIA, ALBERTO ; RACITI, GIOVANNI ; OCCHETTA, ERALDO</creator><creatorcontrib>BOTTO, GIOVANNI LUCA ; DICANDIA, COSIMO DAMIANO ; MANTICA, MASSIMO ; ROSA, CONCETTO LA ; D'ONOFRIO, ANTONIO ; BONGIORNI, MARIA GRAZIA ; MOLON, GIULIO ; VERLATO, ROBERTO ; VILLANI, GIOVANNI QUINTO ; SCACCIA, ALBERTO ; RACITI, GIOVANNI ; OCCHETTA, ERALDO</creatorcontrib><description><![CDATA[CRT Patient Characteristics and Outcomes. Introduction: The characteristics and outcomes of patients who undergo cardiac resynchronization therapy (CRT) device implantation in current clinical practice may differ from those of reference trial populations. Study objectives were to assess 2‐year outcomes in a population implanted with a CRT plus defibrillator device in accordance with the standard of care and to evaluate any independent association between clinical variables and outcome. Methods and Results: A total of 406 patients enrolled at 35 centers in Italy were followed up prospectively for 2 years. All patient management decisions were left to the treating physician's discretion, in accordance with clinical practice. ACTION‐HF patients had a better baseline clinical status than patients enrolled in the COMPANION study: shorter HF history (1 vs 3.5 years, P < 0.01), less advanced NYHA functional class (III–IV: 73% vs 100%, P < 0.01), higher LVEF (26% vs 21%, P < 0.01), higher SBP (122 vs 112 mmHg, P < 0.01), and less diabetes (27% vs 41%, P < 0.01). This status was reflected in lower mortality (11.5% vs 26%) and a lower incidence of appropriate ICD shocks (12.1% vs 19.3%). AF history was an independent predictor of the combination of all‐cause mortality and cardiac‐cause hospitalization (HR: 3.31; P < 0.001). Recurrent or new atrial arrhythmias were independently associated with the development of ventricular arrhythmias (HR: 3.4; P < 0.001). Conclusions : This population appears clinically less compromised and had a lower incidence of adverse clinical outcomes than those of reference trials. However, we recorded a substantial burden of atrial arrhythmias, which was independently associated with a higher incidence of ventricular arrhythmias. (J Cardiovasc Electrophysiol, Vol. 24, pp. 173‐181, February 2013)]]></description><identifier>ISSN: 1045-3873</identifier><identifier>EISSN: 1540-8167</identifier><identifier>DOI: 10.1111/jce.12023</identifier><identifier>PMID: 23130781</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>all-cause mortality. atrial fibrillation ; Cardiac arrhythmia ; cardiac resynchronization therapy ; Cardiac Resynchronization Therapy - mortality ; Cardiac Resynchronization Therapy - utilization ; Cardiac Resynchronization Therapy Devices - utilization ; Clinical medicine ; COMPANION ; Drug therapy ; Female ; heart failure ; Hospitalization - statistics &amp; numerical data ; Humans ; Incidence ; Italy - epidemiology ; Male ; Mortality ; Risk Factors ; Survival Analysis ; Survival Rate ; Tachycardia, Ventricular - mortality ; Tachycardia, Ventricular - prevention &amp; control ; Treatment Outcome ; Ventricular Fibrillation - mortality ; Ventricular Fibrillation - prevention &amp; control</subject><ispartof>Journal of cardiovascular electrophysiology, 2013-02, Vol.24 (2), p.173-181</ispartof><rights>2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243</citedby><cites>FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23130781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BOTTO, GIOVANNI LUCA</creatorcontrib><creatorcontrib>DICANDIA, COSIMO DAMIANO</creatorcontrib><creatorcontrib>MANTICA, MASSIMO</creatorcontrib><creatorcontrib>ROSA, CONCETTO LA</creatorcontrib><creatorcontrib>D'ONOFRIO, ANTONIO</creatorcontrib><creatorcontrib>BONGIORNI, MARIA GRAZIA</creatorcontrib><creatorcontrib>MOLON, GIULIO</creatorcontrib><creatorcontrib>VERLATO, ROBERTO</creatorcontrib><creatorcontrib>VILLANI, GIOVANNI QUINTO</creatorcontrib><creatorcontrib>SCACCIA, ALBERTO</creatorcontrib><creatorcontrib>RACITI, GIOVANNI</creatorcontrib><creatorcontrib>OCCHETTA, ERALDO</creatorcontrib><title>Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study</title><title>Journal of cardiovascular electrophysiology</title><addtitle>J Cardiovasc Electrophysiol</addtitle><description><![CDATA[CRT Patient Characteristics and Outcomes. Introduction: The characteristics and outcomes of patients who undergo cardiac resynchronization therapy (CRT) device implantation in current clinical practice may differ from those of reference trial populations. Study objectives were to assess 2‐year outcomes in a population implanted with a CRT plus defibrillator device in accordance with the standard of care and to evaluate any independent association between clinical variables and outcome. Methods and Results: A total of 406 patients enrolled at 35 centers in Italy were followed up prospectively for 2 years. All patient management decisions were left to the treating physician's discretion, in accordance with clinical practice. ACTION‐HF patients had a better baseline clinical status than patients enrolled in the COMPANION study: shorter HF history (1 vs 3.5 years, P < 0.01), less advanced NYHA functional class (III–IV: 73% vs 100%, P < 0.01), higher LVEF (26% vs 21%, P < 0.01), higher SBP (122 vs 112 mmHg, P < 0.01), and less diabetes (27% vs 41%, P < 0.01). This status was reflected in lower mortality (11.5% vs 26%) and a lower incidence of appropriate ICD shocks (12.1% vs 19.3%). AF history was an independent predictor of the combination of all‐cause mortality and cardiac‐cause hospitalization (HR: 3.31; P < 0.001). Recurrent or new atrial arrhythmias were independently associated with the development of ventricular arrhythmias (HR: 3.4; P < 0.001). Conclusions : This population appears clinically less compromised and had a lower incidence of adverse clinical outcomes than those of reference trials. However, we recorded a substantial burden of atrial arrhythmias, which was independently associated with a higher incidence of ventricular arrhythmias. (J Cardiovasc Electrophysiol, Vol. 24, pp. 173‐181, February 2013)]]></description><subject>all-cause mortality. atrial fibrillation</subject><subject>Cardiac arrhythmia</subject><subject>cardiac resynchronization therapy</subject><subject>Cardiac Resynchronization Therapy - mortality</subject><subject>Cardiac Resynchronization Therapy - utilization</subject><subject>Cardiac Resynchronization Therapy Devices - utilization</subject><subject>Clinical medicine</subject><subject>COMPANION</subject><subject>Drug therapy</subject><subject>Female</subject><subject>heart failure</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Incidence</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Mortality</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><subject>Survival Rate</subject><subject>Tachycardia, Ventricular - mortality</subject><subject>Tachycardia, Ventricular - prevention &amp; control</subject><subject>Treatment Outcome</subject><subject>Ventricular Fibrillation - mortality</subject><subject>Ventricular Fibrillation - prevention &amp; control</subject><issn>1045-3873</issn><issn>1540-8167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp1kd9u0zAUhyMEYmNwwQsgS9yA1Gy2T2Kn3HVhW4vGhkoHl5ZjO6u7_Cm2Iwivw4virdsukLBk-ej4O5-O9EuS1wQfkniONsocEoopPEn2SZ7htCCMP401zvIUCg57yQvvNxgTYDh_nuxRIIB5QfaTP2VjO6tkg8q1dFIF46wPVvkJ-ty7IBsbxgkqpdNWKjTv_dbeNn_LYPtugmSn0TfTBWfV0EiHZs6tx7BurfTIduhLxOKvR1edNu66t901Kper9CNatNtGduFO8wEtjR-aiPU1CmuDZuVqcXmRzk_R1zDo8WXyrJaNN6_u34Pk6vRkVc7T88uzRTk7TxVMCaSGUgBQmvO8wCpTBGhdAyWSqnrKKqM1Y7qqClbXlckyHm9VU80N4zLjNIOD5N3Ou3X9j8H4IFrrlWnioqYfvCBAGHA2zUlE3_6DbvrBdXE7QWgBlGbTnEfq_Y5SrvfemVpsnW2lGwXB4jY5EZMTd8lF9s29cahaox_Jh6gicLQDftrGjP83iU_lyYMy3U3ERM2vxwnpbgTjwHPx_eJMHPNimR-zXMzhL5OhsgI</recordid><startdate>201302</startdate><enddate>201302</enddate><creator>BOTTO, GIOVANNI LUCA</creator><creator>DICANDIA, COSIMO DAMIANO</creator><creator>MANTICA, MASSIMO</creator><creator>ROSA, CONCETTO LA</creator><creator>D'ONOFRIO, ANTONIO</creator><creator>BONGIORNI, MARIA GRAZIA</creator><creator>MOLON, GIULIO</creator><creator>VERLATO, ROBERTO</creator><creator>VILLANI, GIOVANNI QUINTO</creator><creator>SCACCIA, ALBERTO</creator><creator>RACITI, GIOVANNI</creator><creator>OCCHETTA, ERALDO</creator><general>Blackwell Publishing Inc</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201302</creationdate><title>Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study</title><author>BOTTO, GIOVANNI LUCA ; DICANDIA, COSIMO DAMIANO ; MANTICA, MASSIMO ; ROSA, CONCETTO LA ; D'ONOFRIO, ANTONIO ; BONGIORNI, MARIA GRAZIA ; MOLON, GIULIO ; VERLATO, ROBERTO ; VILLANI, GIOVANNI QUINTO ; SCACCIA, ALBERTO ; RACITI, GIOVANNI ; OCCHETTA, ERALDO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>all-cause mortality. atrial fibrillation</topic><topic>Cardiac arrhythmia</topic><topic>cardiac resynchronization therapy</topic><topic>Cardiac Resynchronization Therapy - mortality</topic><topic>Cardiac Resynchronization Therapy - utilization</topic><topic>Cardiac Resynchronization Therapy Devices - utilization</topic><topic>Clinical medicine</topic><topic>COMPANION</topic><topic>Drug therapy</topic><topic>Female</topic><topic>heart failure</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Incidence</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Mortality</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><topic>Survival Rate</topic><topic>Tachycardia, Ventricular - mortality</topic><topic>Tachycardia, Ventricular - prevention &amp; control</topic><topic>Treatment Outcome</topic><topic>Ventricular Fibrillation - mortality</topic><topic>Ventricular Fibrillation - prevention &amp; control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOTTO, GIOVANNI LUCA</creatorcontrib><creatorcontrib>DICANDIA, COSIMO DAMIANO</creatorcontrib><creatorcontrib>MANTICA, MASSIMO</creatorcontrib><creatorcontrib>ROSA, CONCETTO LA</creatorcontrib><creatorcontrib>D'ONOFRIO, ANTONIO</creatorcontrib><creatorcontrib>BONGIORNI, MARIA GRAZIA</creatorcontrib><creatorcontrib>MOLON, GIULIO</creatorcontrib><creatorcontrib>VERLATO, ROBERTO</creatorcontrib><creatorcontrib>VILLANI, GIOVANNI QUINTO</creatorcontrib><creatorcontrib>SCACCIA, ALBERTO</creatorcontrib><creatorcontrib>RACITI, GIOVANNI</creatorcontrib><creatorcontrib>OCCHETTA, ERALDO</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cardiovascular electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOTTO, GIOVANNI LUCA</au><au>DICANDIA, COSIMO DAMIANO</au><au>MANTICA, MASSIMO</au><au>ROSA, CONCETTO LA</au><au>D'ONOFRIO, ANTONIO</au><au>BONGIORNI, MARIA GRAZIA</au><au>MOLON, GIULIO</au><au>VERLATO, ROBERTO</au><au>VILLANI, GIOVANNI QUINTO</au><au>SCACCIA, ALBERTO</au><au>RACITI, GIOVANNI</au><au>OCCHETTA, ERALDO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study</atitle><jtitle>Journal of cardiovascular electrophysiology</jtitle><addtitle>J Cardiovasc Electrophysiol</addtitle><date>2013-02</date><risdate>2013</risdate><volume>24</volume><issue>2</issue><spage>173</spage><epage>181</epage><pages>173-181</pages><issn>1045-3873</issn><eissn>1540-8167</eissn><abstract><![CDATA[CRT Patient Characteristics and Outcomes. Introduction: The characteristics and outcomes of patients who undergo cardiac resynchronization therapy (CRT) device implantation in current clinical practice may differ from those of reference trial populations. Study objectives were to assess 2‐year outcomes in a population implanted with a CRT plus defibrillator device in accordance with the standard of care and to evaluate any independent association between clinical variables and outcome. Methods and Results: A total of 406 patients enrolled at 35 centers in Italy were followed up prospectively for 2 years. All patient management decisions were left to the treating physician's discretion, in accordance with clinical practice. ACTION‐HF patients had a better baseline clinical status than patients enrolled in the COMPANION study: shorter HF history (1 vs 3.5 years, P < 0.01), less advanced NYHA functional class (III–IV: 73% vs 100%, P < 0.01), higher LVEF (26% vs 21%, P < 0.01), higher SBP (122 vs 112 mmHg, P < 0.01), and less diabetes (27% vs 41%, P < 0.01). This status was reflected in lower mortality (11.5% vs 26%) and a lower incidence of appropriate ICD shocks (12.1% vs 19.3%). AF history was an independent predictor of the combination of all‐cause mortality and cardiac‐cause hospitalization (HR: 3.31; P < 0.001). Recurrent or new atrial arrhythmias were independently associated with the development of ventricular arrhythmias (HR: 3.4; P < 0.001). Conclusions : This population appears clinically less compromised and had a lower incidence of adverse clinical outcomes than those of reference trials. However, we recorded a substantial burden of atrial arrhythmias, which was independently associated with a higher incidence of ventricular arrhythmias. (J Cardiovasc Electrophysiol, Vol. 24, pp. 173‐181, February 2013)]]></abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>23130781</pmid><doi>10.1111/jce.12023</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1045-3873
ispartof Journal of cardiovascular electrophysiology, 2013-02, Vol.24 (2), p.173-181
issn 1045-3873
1540-8167
language eng
recordid cdi_proquest_miscellaneous_1316376951
source Wiley
subjects all-cause mortality. atrial fibrillation
Cardiac arrhythmia
cardiac resynchronization therapy
Cardiac Resynchronization Therapy - mortality
Cardiac Resynchronization Therapy - utilization
Cardiac Resynchronization Therapy Devices - utilization
Clinical medicine
COMPANION
Drug therapy
Female
heart failure
Hospitalization - statistics & numerical data
Humans
Incidence
Italy - epidemiology
Male
Mortality
Risk Factors
Survival Analysis
Survival Rate
Tachycardia, Ventricular - mortality
Tachycardia, Ventricular - prevention & control
Treatment Outcome
Ventricular Fibrillation - mortality
Ventricular Fibrillation - prevention & control
title Clinical Characteristics, Mortality, Cardiac Hospitalization, and Ventricular Arrhythmias in Patients Undergoing CRT-D Implantation: Results of the ACTION-HF Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T17%3A57%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Characteristics,%20Mortality,%20Cardiac%20Hospitalization,%20and%20Ventricular%20Arrhythmias%20in%20Patients%20Undergoing%20CRT-D%20Implantation:%20Results%20of%20the%20ACTION-HF%20Study&rft.jtitle=Journal%20of%20cardiovascular%20electrophysiology&rft.au=BOTTO,%20GIOVANNI%20LUCA&rft.date=2013-02&rft.volume=24&rft.issue=2&rft.spage=173&rft.epage=181&rft.pages=173-181&rft.issn=1045-3873&rft.eissn=1540-8167&rft_id=info:doi/10.1111/jce.12023&rft_dat=%3Cproquest_cross%3E2879959971%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3913-e22333cd77580c4c132ff321a2cf96bedd66dbb86ffbe447e44bf2d7e67a47243%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1283224957&rft_id=info:pmid/23130781&rfr_iscdi=true